MedTrace Logo

Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture

NCT05822804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2025-07-23

No results posted yet for this study

Summary

The purpose of this study is to verify the safety and efficacy of the Vascular Closure Device (Tonbridge) in hemostasis treatment for femoral artery puncture.

Conditions

  • Vascular Closure
  • Endovascular Procedure
  • Hemostasis
  • Femoral Artery
  • Puncture

Interventions

DEVICE

Vascular Closure Device (Tonbridge)

Hemostasis treatment for femoral artery puncture with Vascular Closure Device (Tonbridge).

DEVICE

EXOSEAL Vascular Closure Device (Codis Corporation)

Hemostasis treatment for femoral artery puncture with EXOSEAL Vascular Closure Device (Codis Corporation).

Sponsors & Collaborators

  • Ton-Bridge Medical Tech. Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Tianxiao Li · Henan Provincial People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-22
Primary Completion
2024-01-27
Completion
2024-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05822804 on ClinicalTrials.gov